An-Najah National University Faculty of Graduate Studies Synthesis of zinc oxide and cobalt oxide nanoparticles in surfactant / antibiotics shell and investigating their anti-bacterial activities By Alaa Qasem Abed-Alkareem Al-Haj Qasem Supervisor Dr. Amjad Hussein Co-supervisor Dr. Mohammed Suleiman This Thesis is Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science in Biology, Faculty of Graduate Studies, An-Najah National University, Nablus, Palestine. 2013 iii Dedication To my Prophet Mohammad (peace be upon him) Then,, To my beloved mother, father and family, dear sisters and all who gave me help and support throughout my life. iv Acknowledgment At the beginning, thanks Allah for what I have now… I would like to express my special thanks to Dr. Amjad Hussien and Dr. Mohammad Suleiman for their supervision. Without their endless support and help this work could not be achieved. I'd like to thank the technical staff in Biology, Chemistry and Medical Laboratory Sciences Departments, for their technical help. Thanks for Dr. Firas Qanaze from the college of pharmacy / An-Najah National University and Dr. Dimitrios Bikiaris, Aristotle University of Thessaloniki, Chemistry Department, Laboratory of Polymer Chemistry and Technology for their kind help in the chemical characterization of nanoparticles. Also thanks for Mr. Diya' Aref, Mr. Moath Bari and Mr. Yousef Salamah for their help during the laboratory work. Finally, my great thanks and supplication to my mother, father, sisters and brothers especially the younger one, Mostafa, for their support and help. And I can't forget my beloved friends, their encouragement was my motivation. v ﺭﺍﺭﻗﻹﺍ :ﻥﺍﻭﻨﻌﻝﺍ لﻤﺤﺘ ﻲﺘﻝﺍ ﺔﻝﺎﺴﺭﻝﺍ ﺔﻌﻗﻭﻤ ﻩﺎﻨﺩﺃ ﻊﻗﻭﻤﻝﺍ ﺎﻨﺃ Synthesis of zinc oxide and cobalt oxide nanoparticles in surfactant / antibiotics shell and investigating their anti-bacterial activities ﺩ ﺍﻭﻤﻝﺎﺒ ﺎﻬﻔﻴﻠﻐﺘﻭ ﻭﻨﺎﻨﻝﺍ ﻡﺎﺠﺤﺄﺒ ﺕﻝﺎﺒﻭﻜﻝﺍ ﺩﻴﺴﻜﺃﻭ ﻙﻨﺯﻝﺍ ﺩﻴﺴﻜﺃ ﺭﻴﻀﺤﺘ ﺔﻴﺭﻴﺘﻜﺒ ﺕﺍﺩﺎﻀﻤﻜ ﺎﻫﺭﻴﺜﺄﺘ ﺔﺴﺍﺭﺩﻭ ﺔﻴﻭﻴﺤﻝﺍ ﺕﺍﺩﺎﻀﻤﻝﺍ / ﺎﻴﺤﻁﺴ ﺔﻝﺎﻌﻔﻝﺍ ﻪﻴﻝﺍ ﺓﺭﺎﺸﻻﺍ ﺕﻤﺘ ﺎﻤ ﺀﺎﻨﺜﺘﺴﺎﺒ ،ﺹﺎﺨﻝﺍ ﻱﺩﻬﺠ ﺝﺎﺘﻨ ﻭﻫ ﺔﻝﺎﺴﺭﻝﺍ ﻪﻴﻠﻋ ﺕﻠﻤﺘﺸﺍ ﺎﻤ ﻥ ﺄﺒ ﺭﻗﺃ ﺏـﻘﻝ ﻭﺃ ﺔـﺠﺭﺩ ﻱﺃ لﻴﻨﻝ لﺒﻗ ﻥﻤ ﻡﺩﻘﻴ ﻡﻝ ﺎﻬﻨﻤ ﺀﺯﺠ ﻱﺃ ﻭﺃ ،لﻜﻜ ﺔﻝﺎﺴﺭﻝﺍ ﻩﺫﻫ ﻥﺃﻭ ،ﺩﺭﻭ ﺎﻤﺜﻴﺤ .ﻯﺭﺨﺃ ﺔﻴﺜﺤﺒ ﻭﺃ ﺔﻴﻤﻴﻠﻌﺘ ﺔﺴﺴﺅﻤ ﻱﺃ ﻯﺩﻝ ﻲﺜﺤﺒ ﻭﺃ ﻲﻤﻠﻋ Declaration The work provided in this thesis, unless otherwise referenced, is the researcher's own work, and has not been submitted elsewhere for any other degree or qualification. Students name: :ﺔﺒﻝﺎﻁﻝﺍ ﻡﺴﺍ Signature: :ﻊﻴﻗﻭﺘﻝﺍ Date: :ﺦﻴﺭﺎﺘﻝﺍ vi List of Abbreviation Symbol Abbreviation A ° Angstrom AFM Atomic Force Microscopy B. subtilis Bacillus subtilis bacteria CoO Cobalt oxide DMSO Dimethylsulphoxide E. coli Escherichia coli bacteria EDX Energy Dispersive X-ray FWHM Full width at half maximum GRAS Generally Recognized As Safe M Molarity MBC Minimum bactericidal concentration MIC Minimum inhibitory concentration NA Nutrient Agar NB Nutrient Broth nm Nanometer NP Nanoparticles QAS Quaternary Ammonium Surfactants S. aureus Staphylococcus aureus bacteria SEM Scanning Electron Microscopy TOA Tetra octyl ammonium salts TOAB Tetraoctyl ammonium bromide XRD X-ray diffraction ZnO Zinc oxide vii Table of Contents No. Content Page Dedication iii Acknowledgment iv Declaration v List of abbreviations vi Table of contents vii List of tables x List of figures xii Abstract xiv Chapter One: Literature review 1 Chapter Two: Introduction 7 2.1 Naoparticles 8 2.2 Stabilizers 9 2.3 Zinc and Cobalt oxide nanoparticles 10 2.3.1 Zinc oxide nanoparicles 10 2.3.2 Zinc oxide nanoparicles stabilized in surfactant 12 Zinc oxide nanoparicles stabilized in surfactant and 2.3.3 12 mixed with antibiotics Cobalt oxide nanoparicles, cobalt oxide nanoparicles 2.3.4 stabilized in surfactant, cobalt oxide nanoparticles 13 stabilized in surfactant and mixed with antibiotics 2.4 Bacterial strains 14 2.4.1 Staphylococcus aureus 14 2.4.2 Bacillus subtilis 15 2.4.3 Escherichia coli 16 2.5 Antibiotics 17 2.5.1 Amoxicillin 17 2.5.2 Cephalexin 17 2.5.3 Streptomycin 18 2.6 The toxicological effect of nanoparticles on human 18 2.7 Objectives of this study 19 Chapter three: Methodology 21 3.1 Chemicals and Materials 22 3.2 Sample preparation 23 3.2.1 Zinc oxide nanoparticles preparation 23 Zinc oxide nanoparticles stabilized in TOAB 3.2.2 23 preparation 3.2.3 Cobalt oxide nanoparticles preparation 23 Cobalt oxide nanoparticles stabilized in TOAB 3.2.4 24 preparation viii No. Content Page 3.3 Samples characterization 24 3.3.1 X-ray diffraction (XRD) 24 Scanning Electron Microscopy (SEM) and Energy 3.3.2 25 Dispersive X-ray Spectroscopy (EDX) 3.4 Antibacterial activity 25 3.4.1 Bacterial isolates 25 3.4.2 Bacterial culture preparation 26 3.4.2.1 McFarland preparation 26 3.4.2.2 Nutrient broth preparation 26 3.4.3 pH examination 27 3.4.4 Serial dilution preparation and MIC determination 27 The ratios of nanoparticles stabilized in TOAB to 3.4.5 29 Antibiotics Chapter four: Results and Discussion 30 4.1 Nanoparticles characterization 31 4.1.1 X-ray diffraction (XRD) 31 4.1.1.1 X-ray characterization of zinc oxide nanoparticles 31 X-ray characterization of zinc oxide nanoparticles 4.1.1.2 33 stabilized in TOAB 4.1.1.3 X-ray characterization of cobalt oxide nanoparticles 33 X-ray characterization of cobalt oxide nanoparticles 4.1.1.4 34 stabilized in TOAB 4.1.2 Scanning Electron Microscopy Characterization (SEM) 35 4.1.2.1 SEM characterization of zinc oxide nanoparticles 35 SEM characterization of zinc oxide nanoparticles 4.1.2.2 36 stabilized in TOAB 4.1.2.3 SEM characterization of cobalt oxide nanoparticles 37 SEM characterization of cobalt oxide nanoparticles 4.1.2.4 38 stabilized in TOAB Energy Dispersive X-ray Spectroscopy 4.1.3 38 Characterization(EDX) 4.1.3.1 EDX characterization of zinc oxide nanoparticles 38 4.1.3.2 EDX characterization of zinc oxide nanoparticles 39 stabilized in TOAB 4.1.3.3. EDX characterization of cobalt oxide nanoparticles 40 EDX characterization of cobalt oxide nanoparticles 4.1.3.4 41 stabilized in TOAB. 4.2 Antibacterial Activity 42 The antibacterial activity of tetra-octyl ammonium 4.2.1 43 bromide (TOAB) ix No. Content Page The antibacterial activity of dimethyl-sulphoxide 4.2.2 44 (DMSO) 4.2.3 The antibacterial activity of nanoparticles 45 4.2.3.1 Zinc oxide Nanoparticles 46 4.2.3.2 Cobalt oxide Nanoparticles 49 4.2.4 Antibacterial activity of antibiotics 51 The antibacterial activity of nanoparticles oxides 4.2.5 55 stabilized in TOAB and mixed with antibiotics The antibacterial activity of zinc oxide nanoparticles 4.2.5.1 56 stabilized in TOAB and mixed with antibiotics The antibacterial activity of cobalt oxide nanoparticles 4.2.5.2 61 stabilized in TOAB and mixed with antibiotics Conclusion 66 Suggestions for further work 69 References 70 Appendix 77 ﺹﺨﻠﻤﻝﺍ ﺏ x List of Tables No. Tables Page Table (4.1) EDX analysis of ZnO-NPs 39 Table (4.2) EDX analysis of ZnO-NPs stabilized in TOAB 40 Table (4.3) EDX analysis of CoO-NPs 40 Table (4.4) EDX analysis of CoO-NPs stabilized in TOAB 41 Table (4.5) The antibacterial activity of TOAB 43 Table (4.6) The antibacterial activity of DMSO 44 The antibacterial activity of zinc oxide Table (4.7) 46 nanoparticles The antibacterial activity of zinc oxide Table (4.8) 47 nanoparticles stabilized in TOAB The antibacterial activity of cobalt oxide Table (4.9) 49 nanoparticles The antibacterial activity of cobalt oxide Table (4.10) 50 nanoparticles stabilized in TOAB Table (4.11) The antibacterial activity of amoxicillin 52 Table (4.12) The antibacterial activity of cephalexin 53 Table (4.13) The antibacterial activity of streptomycin 55 The antibacterial activity of zinc Table (4.14) oxidenanoparticles stabilized in TOAB and mixed 56 with amoxicillin The antibacterial activity of zinc oxide Table (4.15) nanoparticles stabilized in TOAB and mixed with 58 cephalexin The antibacterial activity of zinc oxide Table (4.16) nanoparticles stabilized in TOAB and mixed with 59 streptomycin The antibacterial activity of cobalt oxide Table (4.17) nanoparticles stabilized in TOAB and mixed with 61 amoxicillin The antibacterial activity of cobalt oxide Table (4.18) nanoparticles stabilized in TOAB and mixed with 62 cephalexin The antibacterial activity of cobalt oxide Table (4.19) nanoparticles stabilized in TOAB and mixed with 64 streptomycin
Description: